Top Story
Pear Therapeutics, Novartis announce commercial launch of reSET
As the first prescription digital therapeutic approved by the FDA, the treatment will be distributed and supported by a specialist-staffed service center.
NovioSense's artist conception of its device in use.

NovioSense's artist conception of its device in use.

Post-Google, what does the glucose-sensing contact lens landscape look like?

​Photo: Courtesy of L'Oréal USA

L'Oréal launches wearable sun exposure monitor through Apple

Latest News

NHS highlights trusted healthcare apps
November 20, 2018
Chilean women's attitudes toward Pap screening reminder texts vary by age
November 20, 2018
Despite potential, mental health app usage remains low, study shows
November 20, 2018
Clinician's path toward innovation
November 20, 2018
Merck KGaA, Palantir's new joint venture looks to tear down cancer research data silos
November 20, 2018
Nicklaus Children's deploys image-based clinical collaboration app from WinguMD
November 19, 2018
AI-enabled cancer screening platform Ezra snags $4M in seed funding
November 19, 2018
Peerfit's fitness benefits platform is now courting consumers
November 19, 2018

More News

Regional News

More Regional News
Chilean women's attitudes toward Pap screening reminder texts vary by age
By Laura Lovett
November 20, 2018
Pear Therapeutics, Novartis announce commercial launch of reSET
By Dave Muoio
November 20, 2018
NovioSense's artist conception of its device in use.

NovioSense's artist conception of its device in use.

Post-Google, what does the glucose-sensing contact lens landscape look like?
By Jonah Comstock
November 20, 2018